Literature DB >> 6561953

Amoxicillin plus clavulanic acid in the treatment of recurrent urinary tract infections.

W Brumfitt, J M Hamilton-Miller.   

Abstract

Forty-four patients (43 female, 1 male), all with a history of recurrent urinary tract infections, were treated with 250 mg of amoxicillin plus 125 mg of clavulanic acid (one tablet of Augmentin) every 8 h for 7 days. The microbiological cure rates were 84% 1 week after the end of treatment and 67% 1 month later. Side effects, which were reported by 20% of the patients, were mild and in no case caused interruption of treatment. In view of the increasing trend in resistance to agents commonly used for the treatment of urinary tract infections in outpatients, the combination of amoxicillin and clavulanic acid may now be considered a first-line drug in patients with recurrent urinary tract infections.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6561953      PMCID: PMC185489          DOI: 10.1128/AAC.25.2.276

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors:  C Reading; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

2.  The use of amoxycillin in treatment of urinary tract infection in general practice.

Authors:  J D Price; J W Harding
Journal:  Br J Clin Pract       Date:  1973-05

3.  Treatment of acute maxillary sinusitis. V. Amoxicillin azidocillin, phenylpropanolamine and pivampicillin.

Authors:  A Axelsson; C Jensen; O Melin; F Singer; C von Sydow
Journal:  Acta Otolaryngol       Date:  1981 Mar-Apr       Impact factor: 1.494

4.  A concise biotyping system for differentiating strains of Escherichia coli.

Authors:  R Gargan; W Brumfitt; J M Hamilton-Miller
Journal:  J Clin Pathol       Date:  1982-12       Impact factor: 3.411

5.  Prevalence and distribution of R plasmid mediated beta-lactamases in Enterobacteriaceae.

Authors:  L Pagani; M Perduca; E Romero
Journal:  Microbiologica       Date:  1982-07

6.  Conventional and two-dose amoxycillin treatment of bacteriuria in pregnancy and recurrent bacteriuria: a comparative study.

Authors:  W Brumfitt; J M Hamilton-Miller; I N Franklin; F M Anderson; G M Brown
Journal:  J Antimicrob Chemother       Date:  1982-09       Impact factor: 5.790

7.  A comparative trial of co-trimoxazole and cephradine in patients with recurrent urinary infections.

Authors:  J Copper; W Brumfitt; J M Hamilton-Miller
Journal:  J Antimicrob Chemother       Date:  1980-03       Impact factor: 5.790

8.  Comparative trial of trimethoprim and co-trimoxazole in recurrent urinary infections.

Authors:  W Brumfitt; J M Hamilton-Miller; H Ludlam; V Damjanovic; R Gargan
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

9.  Treatment of urinary tract infections with a combination of amoxicillin and clavulanic acid.

Authors:  A Iravani; G A Richard
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

10.  Principal beta-lactamases responsible for resistance to beta-lactam antibiotics in urinary tract infections.

Authors:  I N Simpson; P B Harper; C H O'Callaghan
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

View more
  4 in total

Review 1.  Beta-lactamase inhibitors from laboratory to clinic.

Authors:  K Bush
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

Review 2.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

3.  Effect of clavulanic acid on activity of beta-lactam antibiotics in Serratia marcescens isolates producing both a TEM beta-lactamase and a chromosomal cephalosporinase.

Authors:  K Bush; R K Flamm; S Ohringer; S B Singer; R Summerill; D P Bonner
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

Review 4.  Single dose treatment failure in women with acute cystitis.

Authors:  A Ronald; L E Nicolle; G Harding
Journal:  Infection       Date:  1992       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.